Mirtazapine, a mixed-profile serotonin agonist/antagonist, suppresses sleep apnea in the rat.


Serotonin enhancing drugs, including L-tryptophan and, more recently, fluoxetine and paroxetine, have been tested as pharmacologic treatments for sleep apnea syndrome. Although some patients have demonstrated reduced apnea expression after treatment with these compounds, this improvement has been restricted to nonrapid eye movement (NREM) sleep, with some… (More)


  • Presentations referencing similar topics